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This paper focusses on a thermodynamic model built to predict the reduction of organic drugs melting 
temperature and enthalpy with nano-crystals size decrease. Indeed, this valuable information enables 
us to evaluate the increase of drug solubility, an aspect of paramount importance for poorly water-
soluble organic drugs since a solubility increase is reflected in a bioavailability enhancement. In 
particular, the model considers the effect of nano-crystals shape (spherical, cylindrical and 
parallelepiped-shaped) and morphology (from platelet to needle nano-crystals) on the melting 
temperature and enthalpy reduction with crystals size decrease. Nimesulide, a typical nonsteroidal 
and poorly water-soluble drug with anti-inflammatory action, has been chosen as a model drug to test 
model reliability. Model outcomes suggest that the reduction of melting temperature and enthalpy 
mainly depends on the ratio between crystals surface area and volume, i.e. on the ratio between the 
number of surface and bulk molecules constituting the nano-crystal network. The obtained prediction 
of solubility enhancement and the successful comparison with the outcomes obtained from a 
molecular dynamics approach, in terms of melting temperature and enthalpy decrease, have 





As the oral route has always been the simplest and most appreciated way to administer drugs, many 
efforts were made in the past to render this administration way also practicable for poorly water-
soluble drugs which are usually characterized by low bioavailability1 and represent, approximately, 
40% of the drugs being in the development pipelines. In addition, up to 60% of synthesized 
compounds are poorly soluble2 and 70% of potential drug candidates are discarded due to low 
bioavailability related to poor solubility in water.3 Examples of commonly marketed poorly soluble 
drugs (water solubility less than 100 g cm-3) include analgesics, cardiovasculars, hormones, 
antivirals, immune suppressants and antibiotics.1 Thus far, an effective solution to increase the 
bioavailability of poorly soluble drugs has appeared to be nanonization, i.e. pulverizing solid 
substances into the nano-meter range, which dramatically increases the crystal surface-volume ratio 
and the solid-liquid interface. This immediately translates into nano-crystals melting temperature (Tm) 
and enthalpy reduction (Hm),
4 which, as a result, is reflected in the increase of drug water solubility 
and, in turn, drug bioavailability as discussed in the Results and Discussion section. 
A valid explanation for this phenomenon is the different arrangement of surface and bulk phases. In 
fact, surface atoms/molecules present fewer bonds than the bulk ones5 and, accordingly, higher 
energy content. Therefore, surface lattice destruction necessitates less energy and is favored in 
comparison to the bulk one. Molecular dynamics simulation (MD) and experimental data regarding 
Au nano-crystals confirmed the previous theoretical analysis6,7 by highlighting the different behavior 
between surface and bulk atoms. As a matter of fact, the coherent electron patterns diffracted by 
single nano-crystals depend on the atomic structure of surfaces. This interpretation, valid for metals, 
may be also extended to organic substances.8 Indeed, the fundamentally vibrational melting entropy 
of organic crystals implies that organic molecules in crystalline arrangement behave analogously to 
metals. This indicates that the peculiar properties of organic nano-crystals may be investigated by 
means of the same theoretical models employed for metallic nano-crystals. Indeed, the melting 
4 
 
entropy of organic crystals is essentially constituted by a vibrational component, which implies that 
molecules in organic crystals exhibit a similarity to atoms in metallic crystals. Accordingly, for the 
molecular solids, the difference in activation energy between surface and bulk may be explained by 
a difference in molecular mobility.8 Obviously, the surface atoms/molecules effect is macroscopically 
detectable only if their number is comparable to the bulk one, that is when the surface-volume ratio 
is no longer negligible as it happens in nano-crystals. 
Several researchers,9 both experimentally and theoretically, investigated melting properties in 
connection with crystal size, whereas solubility dependence is still controversial due to experimental 
measurement difficulties.1,10 In particular, manufacturing processes, usually altering surface 
characteristics by introducing lattice defects, hinder the use of fine crystals for experimental solubility 
determination.11 Little impurities are able to affect solubility and poly-dispersed crystals experience 
Ostwald ripening,12 the growth of larger crystals at the expense of the smaller ones, which leads to an 
asymptotic solubility diminution. Therefore, in the light of these considerable experimental 
difficulties, the theoretical determination of drug solubility vs. nano-crystals size has become 
mandatory. Despite the previously discussed experimental issues, the manufacturing of nano-crystal-
based drug delivery systems is feasible without particular difficulties. For instance, solvent 
swelling,13,14 supercritical carbon dioxide,15,16 co-grinding,17–21 and cryomilling22 allow the dispersion 
of the drug, in form of nano-crystals or amorphous state, inside a carrier, typically an amorphous 
crosslinked polymer.23 Indeed, the polymer acts as a stabilizer for nano-crystals/amorphous drugs 
which, otherwise, tend to recrystallize back to their more thermodynamically stable macro-crystals 
status. The presence of drug and stabilizer generates a distribution of particles with different sizes, 
e.g. the secondary grains, which are composed of crystals, e.g. the primary grains, connected by an 
amorphous phase that is constituted, in turn, by the amorphous drug and/or the amorphous stabilizing 
agent. Furthermore, primary grains are constituted by short-range structural arrangements 
(crystallites) which are coherent crystalline domains, the size of which is commonly defined crystal 
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dimension.23 Reliability and effectiveness of such delivery systems were proved by in vitro and in 
vivo tests revealing considerable bioavailability improvement of poorly water-soluble but permeable 
drugs,23,24 known as class II drugs according to Amidon classification.25 
Traditionally, the peculiar properties of nano-crystals have been explored in metallurgy26,27 and then 
in material28, 29 and pharmaceutical science30. In particular, Ha and co-workers28, studying the 
crystallization of anthranilic acid (AA) in nanoporous polymer and glass matrices, were the first to 
report on the effect of nano-confinement on organic polymorphic crystals. They demonstrated that 
polymorph selectivity during sublimation of AA was influenced by the surface properties of glass 
substrates. Indeed, the preference for metastable form II in smaller pores could be due to a smaller 
critical nucleus size in comparison with the other two polymorphs (I and III). In another paper, Ha 
and co-workers29, working on the crystallization of organic compounds in nano-channels of 
controlled pore glass and porous polystyrene, detected a clear melting temperature/enthalpy 
depression associated with decreasing channel diameter, this being consistent with the increasing of 
crystals surface/volume ratio. In addition, they found that the melting point depression depended also 
on the properties of the embedding matrix and this was explained by the different nanocrystals 
interactions with the channel walls. While Zandavi demonstrated the validity of thermodynamics at 
least in pores down to a radius of 1.3 nm,31 Beiner and collaborators deepened the understanding of 
the effect of pores morphology on crystals polymorphism32 and the appearance of an amorphous drug 
layer between pore wall and nano-crystal surface due to drug-wall interactions.33 Hasa and co-
workers34 and Belenguer and co-workers35 focused the attention on co-crystals. In particular, Hasa 
and co-workers34 observed how the amount of a specific liquid present during liquid-assisted 
mechanochemical reactions can be used to rapidly explore polymorph diversity. Indeed, for the 
multicomponent crystal system considered, formed by caffeine and anthranilic acid in 1:1 
stoichiometric ratio, only 4 out of 15 liquids were found to be highly selective for one polymorphic 
form, while 11 out of 15 produced more than one co-crystal polymorphs depending on the amount of 
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the liquid used (the selected volume range was 10-100 l). A similar phenomenon was observed by 
Belenguer and co-workers35, by studying other two (dimorphic) systems namely the 1:1 
theophylline:benzamide co-crystal and an aromatic disulfide compound. Importantly, Belenguer and 
co-workers35 also reported a possible explanation why different amounts of a liquid produce different 
polymorphic forms. In fact, such phenomenon was related to the particle size: polymorphs which are 
metastable as micrometer-sized or larger crystals can often be thermodynamically stabilized at the 
nanoscale. Additionally, surface effects were reported to be significant in polymorphism at the 
nanoscale and that the outcomes of equilibrium mechanochemical experiments are in general 
controlled by thermodynamics. If Lee was able to measure amorphous ibuprofen solubility resorting 
to nano-porous aluminum oxide,36 Beiner and his group proved that nano-confinement is a strategy 
to produce and stabilize otherwise metastable or transient polymorphs of pharmaceuticals, as required 
for controllable and effective drug delivery.37, 38 Myerson and co-workers39, 40 studied the use of 
biocompatible alginate hydrogels as a smart material for crystallizing and encapsulating different 
kinds of drugs (acetaminophen and fenofibrate). Interestingly they found that hydrogels with smaller 
mesh sizes showed faster nucleation kinetics. In addition, Myerson and co-workers41, 42 used pore 
glasses and porous silica supports to get nano-crystals of fenofibrate and griseofulvin thus achieving 
an increased dissolution rate in comparison with that of original macro-crystals. 
In the frame above delineated, the attention of this paper is devoted to nano-crystals embedded/mixed 
in/with an ensemble of crosslinked polymeric micro-particles acting as stabilizing agent for nano-
crystals and amorphous drugs.23 Owing to its low water solubility, good permeability and relevance 
to the industrial pharmaceutical field,1,43 nimesulide (NIM), a classical nonsteroidal anti-
inflammatory drug, was selected as a proof of concept in the present study. 
Thus far, the majority of theoretical approaches have been devoted to investigating the relation 
existing between spherical nano-crystals size and Tm/Hm, and only a few of them considered non-
spherical shapes.26 Moreover, they were focused on metal nano-crystals, but none of them on drug 
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nano-crystals. To the best of our knowledge, no studies aiming at elucidating the effect of nano-
crystals shape on the reduction of Tm/Hm and on the consequent increase of solubility are present in 
literature so far. Accordingly, this paper intends to theoretically study the dependence of Tm/Hm 
decrease on nano-crystals size by means of a thermodynamic model distinguishing crystals shape 
(sphere, cylinder, parallelepiped). In addition, the outcomes of this model were validated against the 




At the beginning of the last century, Tm decrease by means of crystal size reduction was 
thermodynamically predicted and experimentally demonstrated.44 Afterwards, several researchers 
developed theoretical models to explain Tm/Hm depression phenomenon.  
 
Figure 1. The thermodynamic models of nano-crystals melting are based on three mechanisms: 
Homogeneous Melting, Liquid Skin Melting, Liquid Nucleation and Growth. Rv, Rl and Rs are the 
vapor, liquid and solid phases radii, respectively (picture from ref. 49). 
 
Among them, the thermodynamic ones26,45 were confirmed by MD simulations and were potentially 
able to describe different crystal shapes. Furthermore, these models are well adapted to describe the 
phenomena involved in the drug melting process. Fundamentally, thermodynamic models rely on the 
























equilibrium between the solid and the liquid drug phases that share the same mass and lie in the vapor 
phase. The Liquid Skin Melting theory (LSM) presupposes the formation of a thin liquid layer over 
the solid core. The thickness of the liquid layer remains constant until the solid core completely melts. 
According to the Liquid Nucleation and Growth approach (LNG), on the contrary, the liquid layer 
thickness grows approaching Tm. The solid core melting occurs when the liquid layer thickness is no 
longer negligible in comparison to the solid core size. 
Despite the fact that, theoretically, there are no reasons for preferring one of the three mechanisms 
depicted in Figure 1 (HM, LSM, LNG), two distinct physical considerations are in favor of the LSM 
and LNG approaches. The first one relies on the direct observation of drug crystals melting showing 
the formation of a liquid shell around the solid phase before the occurrence of complete melting. The 
second one is strictly related to the structure of the delivery systems relying on drug nano-
crystals/polymer mixtures. Indeed, regardless of the drug loading technique considered (solvent 
swelling, supercritical carbon dioxide, co-grinding and cryomilling), the coexistence of drug nano-
crystals and amorphous drug inside the polymeric matrix is usually observed.46, 47 Thus, when the 
ratio between the amount of the nano-crystalline drug and the amorphous drug is very high (i.e. when 
the nano-crystals mass fraction (Xnc) is close to one), drug melting should occur according to the 
physical description of the LSM approach. On the contrary, when Xnc approaches zero, i.e. when few 
nano-crystals melt inside an amorphous drug rich environment, the LNG theory appears to describe 
the melting process properly. Indeed, in this case, nano-crystals melting occurs in contact with a 
conspicuous drug liquid phase as, regardless of nano-crystals size, melting occurs at a temperature 
higher than the glass transition temperature of the amorphous drug, value over which the amorphous 
drug is liquid and able to flow. Accordingly, it appears reasonable to presume that, upon melting, the 
thickness of the liquid layer surrounding the solid core is no longer negligible in comparison to the 
solid core one. These considerations are based on the visual inspection of NIM crystals melting 
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obtained by means of Hot Stage Microscopy (see the “Nimesulide-Melting.avi” file in the supporting 
information). 
Finally, as the thermodynamic model previously developed for spherical crystals48, 49 not only 
considers the limiting conditions Xnc → 0 (LNG) and Xnc → 1 (LSM), but it is also able to consider 
the more realistic situation 0 ≤ Xnc ≤ 1, the focus of this paper is on the LSM and LNG approaches. 
 
Mathematical frame 
Starting point is the infinitesimal, reversible, variation of the internal energy, E, for closed systems 
composed of k components and 3 phases:50 
lvslsvvls ddddddd EEEEEEE          (1) 
where Es, El and Ev represent the internal energies of the solid, liquid and vapor phases, respectively, 
while Esv, Esl and Elv are the internal energies of the solid/vapor, solid/liquid and liquid/vapor 
interfaces, respectively. Beginning from Eq. (1), the following working equation relating the melting 
















































H        (2) 
where Hm is the specific melting enthalpy (J/kg), s and l are the density of the solid and liquid 
drug phases, respectively, lv,sl, Alv and Asl are the surface energy and the areas of the liquid/vapor 
and solid/liquid interfaces, respectively, while Vv and Vs are the vapor and solid volumes, respectively. 
Eq. (2) has to be adapted to consider the different geometrical shapes (sphere, cylinder, 
parallelepiped) chosen to approximate crystals shape. In particular, this adaptation regards the two 
derivatives dAlv/dVv and dAsl/dVs. Interstingly, assuming that s and l are equal, considering spherical 
crystals, regarding Hm and 
sl independent of temperature and curvature, respectively, integration of 
















         (3) 
where d is crsystal diameter and  represents the contact angle of the solid nanocrystal with the pore 
wall in the case of crystals confined in nanopores. In the case of unconfined nanocrystals (i. e. the 
situation considered in this paper), cos() = -1 ( = 180°). 
Parallelepiped 
 
Figure 2. Spatial disposition of the three drug phases (solid, liquid and vapor) according to the LNG 
and LSM theories. as, bs and cs represent the three dimensions of the parallelepiped solid core,  is 
the thickness of the surrounding liquid layer, while av, bv and cv are the three dimensions of the vapor 
phase. 
 
While it is reasonable and physically sound that, in the case of a spherical crystal, the liquid phase is 
represented by a spherical shell (see Figure 1), the shape assumed by the liquid phase around the solid 
parallelepiped, on the contrary, is less obvious. However, for the sake of simplicity, it is usual to 
assume that the shape of the liquid phase is the same of the solid one.52 Accordingly, Figure 2, 
borrowing, for a parallelepiped, the physical situation depicted in Figure 1, allows evaluating the 
analytical expression of the two derivatives dAlv/dVv and dAsl/dVs: 
         
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where as, bs, cs, av, bv and cv represent the three dimensions of the solid and vapor phases, respectively, 
 is the thickness of the surrounding liquid layer, /as,  bs/as and cs/as. While performing 
the two derivatives, the volume (avbvcv) is assumed constant. 






































































H                    (6) 
where
lvγ and
slγ are, respectively, the surface energy of the liquid/vapor and solid/liquid flat 
interfaces (infinite curvature radius). In order to evaluate the ratio , it is convenient to recall the 
definition of Xnc (the ratio drug nano-crystals mass/drug total mass): 
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The numerical solution of Eq. (7) (Newton’s method) enables the evaluation of the parameter Δ 
required by Eq. (6). It is clear that  → ∞ in the case Xnc → 0 (LNG), while  → 0 when Xnc → 1 
(LSM). In the real case, 0 ≤ Xnc ≤ 1, obviously 0 ≤  < ∞. While Eq. (7) strictly applies to mono-
dispersed nano-crystals, it also holds, on average, for poly-dispersed ones. 
Assuming both s and l constant and independent of as, the integration of Eq. (6) from the melting 
temperature of the infinitely large crystal (Tm∞) to the melting temperature of the nano-crystal with 
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Implicitly, Eq. (9) implies that surface energy (both lvγ  and 
slγ ) is independent of crystal shape (, 
), dimension (as) and crystal facet. As a matter of fact, this assumption is sometimes unverified, as 
nicely documented by Heng and co-workers53 who proved that paracetamol form I crystals exhibit 
different surface energies on distinct crystal facets. In this particular case, the explanation for this 
occurrence was the variable number of hydroxyl groups present on crystal facets. It is worth 
mentioning that, in principle, the derivation of Eq. (9) could also consider surface energy dependence 
on crystal shape, dimension and facet. In particular, in order to take account of surface energy 
dependence on crystal facet, Eq. (9) modification is relatively straightforward provided that the 
surface energy pertaining to each facet is available. 
In order to solve Eq. (9) and obtain Tm dependence on as, it is necessary to evaluate Hm dependence 
on Tm (see the integral in Eq. (9)). In this context, the classic thermodynamic approach employed by 
Zhang and co-workers, holding regardless of nano-crystals nature (organic or inorganic) and being 
characterized by easily determinable parameters, may be considered.9 This approach relies on a 
thermodynamic cycle according to which Hm is the sum of five different contributions. The first is 
due to the aggregation of nano-parallelepipeds with size as into the bulk phase at the nano-crystals 
melting temperature Tm (H1). The second implies the bulk phase heating from Tm to the infinitely 
large crystal melting temperature Tm∞ (H2), while the third represents the bulk phase melting at Tm∞ 
(H3). The fourth implies the bulk liquid disintegration into liquid nano-parallelepipeds with size as 
at Tm∞ (H4) and, finally, the fifth is the cooling of the liquid particles from Tm∞ to the nano-crystals 
melting temperature Tm (H5): 
   
  
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where Hm∞ is the specific melting enthalpy (J/kg) of an infinitely large crystal, V
s and Asv are, 
respectively, the solid phase volume and the area of the solid-vapor interface referring to the ensemble 
of parallelepipeds with dimensions as, bs, cs, V
l and Alv are, respectively, the liquid phase volume and 
the area of the liquid-vapor interface referring to the ensemble of parallelepipeds with dimensions as, 
bs cs, 
svγ  and 





PC are the solid and liquid drug specific heat capacities at constant 
pressure (J/kg K), respectively, whose difference is almost constant and temperature independent.48 
The melting properties dependence on nano-parallelepipeds size as (Tm(as); Hm(as)) is achieved by 
the simultaneous numerical solution of Eq. (9) and Eq. (10) (see Appendix for details). 
 
Cylinder 
Following the same strategy adopted for parallelepipeds, the two derivatives dAlv/dVv and dAsl/dVs 
become, for cylindrical crystals (see Figure 3): 
    
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where /Rs and  Ls/Rs. While performing the two derivatives, the volume vvπ LR





Figure 3. Spatial disposition of the three drug phases (solid, liquid and vapor) according to the LNG 
and LSM theories. Rs and Ls represent the radius and the length of the cylinder solid core, respectively, 
 is the thickness of the surrounding liquid layer, while Rv and Lv are the radius and the length of the 
vapor phase, respectively. 
 
For cylindrical crystals, particular attention has to be paid to the expression of the interface energy 
as, while assuming the lateral surface of the cylinder chemically and physically equal to the two bases, 
the different curvature of the bases (infinite curvature) and the lateral surface (curvature = 1/Rs) have 
to be considered. Indeed, it is well known that surface energy depends on surface curvature according 















           (13) 
where  and ∞ are the energy of a surface with curvature radius r and that of a flat surface (infinite 
curvature radius), respectively, while 0 is Tolman’s length whose order of magnitude should 
correspond to the actual diameter (dm) of the molecules constituting the bulk phase and it is usually 
assumed to be dm/3.
58 Eq. (13) predicts that surface energy tends towards zero for low values of r. 
Hence, according to Eqs. (11)-(13), Eq. (2) becomes: 

























































































Also in this case,  may be evaluated resorting to Xnc: 





































       (16) 
The numerical solution (Newton’s method) of Eq. (16) allows determining the parameter  required 
by Eq. (14). Assuming both s and l independent of Rs, the integration of Eq. (14) from the melting 
temperature of the infinitely large crystal (Tm∞) to the one of the nano-crystal with radius Rs (Tm) 
allows finding the working equation holding for cylinders: 
































































  (17) 
Also in this case, Eq. (17) solution requires the evaluation of Hm on Tm; (see the integral in Eq. (17)) 
and the Zhang’s approach may be used.9 For cylinders, it reads: 
   
  













































































































   (18) 
where Vs and Asv are the solid phase volume and the area of the solid-vapor interface referring to the 
ensemble of cylinders with radius Rs and length Ls, respectively, while V
l and Alv are the liquid phase 
volume and the area of the liquid -vapor interface referring to the ensemble of cylinders with radius 
Rs and length Ls, respectively. Eqs. (17)-(18) inspection reveals that the reduction of surface energy (
sllv γγ , ) with cylinder radius (see Eq. (13)) implies a smaller decrease of both Hm and Tm. 
The melting properties dependence on nano-cylinders radius Rs (Tm(Rs); Hm(Rs)) is achieved by the 




MOLECULAR DYNAMICS CALCULATIONS 
Due to the intrinsic difficulties in obtaining Tm/Hm of specific sized and shaped nano-crystals from 
experimental tests, in the present work, we resorted to MD calculations in order to evaluate the 
aforementioned properties. Atomistic MD simulations explicitly represent atoms constituting a nano-
crystal; as a consequence, Tm/Hm calculation may become computationally unfeasible especially for 
large crystals. In the present study, reference model volumes were selected as the best compromise 
between the computational time required to accurately derive Tm/Hm and the values needed for the 
comparison with the thermodynamic model. The minimum simulated volume in each data set ensures 
the construction of a reliable nano-crystal molecular model featuring at least 3 crystallographic units 
in each direction whatever the nano-crystal shape and shape ratio. 
NIM single crystal structure was retrieved from the Cambridge Structural Database (Cambridge, UK) 
(CCDC 773602).59 NIM orthorhombic Pca21 crystal cell parameters are the following: a 16.1268 Å, 
b 5.0411 Å, c 32.761 Å, α 90°, β 90°, γ 90°. 
Crystal cell was optimized by using the Dreiding force field with charges derived by fitting the 
electrostatic potential surface of the optimized structure at the B3LYP/6-31G (d,p) level by 
Turbomole 7.1 (http://www.turbomole-gmbh.com) and RESP method.60,61 Single crystal NIM nano-
particles (NPs) of appropriate dimensions and shape were built by employing the Nanocluster module 
present in Materials Studio v. 6.1 (Accelrys Inc., USA) program 
(http://accelrys.com/products/collaborative-science/biovia-materials-studio/). Free boundary 
conditions (free surfaces with vacuum) were applied for MD simulations, which were performed 
within the canonical ensemble (NVT) where a constant temperature T was maintained by using the 
Berendsen method in a constant volume V.62 van der Waals and electrostatic interactions were 
modelled by using a Lennard-Jones potential and a group based summation method, respectively, 
truncated at 1.20 nm. A 1 fs time step was used throughout the simulations. NIM NPs were first 
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relaxed at 300 K for 1 ns before heating, which was gradually applied by increasing the NP 
temperature in intervals. Then, the NPs were equilibrated for at least 15 ns at each temperature taking 
the last phase space point of a calculation as an input for the next temperature calculation. The MD 
simulations were run by Materials Studio v. 6.1 software in an in-house cluster.  
Nano-crystals Tm was evaluated by calculating the potential energy per NIM molecule (at each 
temperature, the potential energy was averaged over the last 5 ns of each simulation with at least 500 
independent configurations) upon heating, and then determining the melting point as the temperature 
where the potential energy changes abruptly, at the first-order transition point. In addition, Hm could 
be calculated with the associated increment of the potential energy. 
The computational procedure described above was also applied to two further drug crystal models, 
namely Nifedipine (NIF) and Griseofulvin (GRI). The unit cell of NIF structure (CCDC BICCIZ) has 
the following properties: monoclinic P1, a 10.923 Å, b 10.326 Å, c 14.814 Å, α 90°, β 92.7°, γ 90°. 
GRI (CCDC GRISFL02) has a tetragonal cell and a P41 space group with lattice parameters: a 8.967 
Å, b 8.967 Å, c 19.904 Å, α 90°, β 90°, γ 90°. The COMPASS force field63,64 was applied for these 
molecular dynamics simulations with charged calculated at B3LYP/6-31G(d) level. 
 
RESULTS AND DISCUSSION 
In order to understand the effect of geometry on the considered nano-crystals thermal properties, it is 




















































































   Zhang’s equation  (20) 
To perform a sound comparison among the thermal properties of differently shaped crystals, it is no 
longer possible to refer to sphere radius (Rs), parallelepiped base side (as) and cylinder base radius 
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(Rs). Indeed, in so doing, we would compare Tm and Hm of crystals having different volumes and, 
thus, different masses. As melting is a bulk phenomenon (although it starts from the surface), the 
comparison of the thermal properties have to be referred to nano-crystals characterized by equal 
volume VC (sphere 4Rs
3/3; parallelepiped asbscs; cylinder Rs
2Ls) and, consequently, different Rs and 
as. Accordingly, Eqs. (9)-(10), (17)-(18) and (19)-(20) were solved as functions of as (parallelepiped), 
Rs (cylinder) and Rs (sphere), respectively. Knowing Tm(as or Rs) and Hm(as or Rs), it was, then, 
possible to develop and compare the corresponding trends Tm(VC) and Hm(VC) for the three different 
considered geometries. Model features were explored by considering NIM, a drug belonging to the 
Amidon’s class II (poorly water soluble but permeable drug)25 as a proof of concept. Its physico-
chemical characteristics48,65 are summarized in Table 1. 
 
Table 1. Nimesulide physico-chemical parameters. UCS indicates the diameter of the unit cell 
imagined as a sphere, Mw is the molecular weight, 
slγ , 
lvγ  and 
svγ  are, respectively, the solid-liquid, 
liquid-vapor and solid-vapor surface energy referring to a plane surface (infinite curvature radius), 0 
is the Tolman’s length, s and l are, respectively, the solid and the liquid densities, Tm∞ and Hm∞ 
are, respectively, the melting temperature and enthalpy of the infinitely large crystal, CP is the 
difference between the liquid and the solid specific heat at constant pressure, Vm is the molar volume, 
while Cs is the solubility in water (37°C).  
Formula C13H12N2O5S Ref 
UCS(nm) 1.74 59 
Mw(-) 308.51 43 
slγ (J/m
2) 0.0133 21 
lvγ (J/m
2) 0.0433 21 
svγ (J/m
2) 0.0576 21 
0(nm) 0.2385 21 
s(kg/m
3) 1490.0 21 
l(kg/m
3) 1343.7 21 
Tm∞(°C) 148.7 21 
Hm∞(J/kg) 108720 21 
CP(J/kg°C) 333.3 21 
Vm(m
3/mole) 192*10-6 21 
Cs(g/cm
3) - 37°C, pH 1.2 11.8 ± 0.5 65 
Cs(g/cm






Figure 4. Effect of the shape ratio  = cs/as on the melting temperature Tm (left vertical axis, black 
lines) and enthalpy Hm (right vertical axis, gray lines) of parallelepiped-shaped nano-crystals, 
assuming the nano-crystals mass fraction Xnc = 1 and  = as/bs = 1. as, bs and cs are the dimensions of 
the parallelepiped-shaped crystal, while VC is the crystal volume. The shaded parallelepipeds 
qualitatively represent the shape of the crystals pertaining to the curve they intersect. 
 
Figure 4, showing Tm and Hm depression in the case of parallelepiped-shaped crystals characterized 
by Xnc = 1 and a square basis ( = as/bs = 1), clarifies the effect of the shape ratio  (= cs/as) (the 
representation is inferiorly limited to the volume of approximately four NIM unit cells ≈ 11 nm3). It 
is observable that the shape ratio  affects in a qualitatively similar manner both Tm and Hm, even if 
its effect appears more accentuated for Tm. In particular, Figure 4 shows that, at fixed crystal volume 
(VC), platelet nano-crystals ( = 0.01) are characterized by lower Tm and Hm than rod-shaped ( = 
100) nano-crystals. In addition, both of them show lower Tm and Hm than cubic nano-crystals. 











































the other shapes (rods and platelets). It is worth mentioning that the relation existing between Tm and 
VC is substantially compatible with the outcomes of nucleation theory, which allows determining the 
size (VC) of the smallest nucleus (namely a cluster of molecules) which a crystal originates from.
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Figure 5. Eq. (20) plot showing the dependence of the dimensionless ratio between crystal surface 
(As) and volume (Vs) on the shape ratio  = cs/ac at constant volume. The value  = bs/ac = 1 was 
assumed to perform a coherent connection with Figure 4. The shaded parallelepipeds qualitatively 
represent the shape of the crystals pertaining to the different  values. 
 
This model output is explicable remembering what was observed by Magomedov66,67 and presented 
in the introduction, i.e. the importance of the ratio between the surface and bulk molecules. Indeed, 
at constant volume (VC), cubic crystals show the minimum surface-volume ratio with respect to the 



























Aac          (21) 
where ac stands for the side of the cube, while A
s and Vs (= VC = acbccc) are the surface and the volume 



















crystals with respect to rod crystals (Figure 5) explains why platelet crystals are characterized by 
lower Tm and Hm in comparison to rod crystals.  
 
Figure 6. Effect of the shape ratio  = Ls/Rs on the melting temperature Tm (left vertical axis, black 
lines) and enthalpy Hm (right vertical axis, gray lines) of cylindrical nano-crystals assuming the 
nano-crystals mass fraction Xnc = 1. Ls and Rs are the length and the radius of the cylindrical-shaped 
crystal, while VC is the crystal volume. The shaded cylinders qualitatively represent the shape of the 
crystals pertaining to the curve they intersect. 
 
In the case of cylindrical crystals, model results (Eqs. (17)-(18)) are qualitatively similar to those 
found for parallelepipeds. Indeed, Figure 6, showing the effect of the shape ratio  on Tm and Hm 
depression, reveals that rod-shaped ( = 200; black/gray solid thickest lines) and platelet-shaped ( 
= 0.02; black/gray dotted lines) crystals are characterized by more consistent reductions of Tm and 
Hm than those referring to the equilateral cylinder ( = 2; black/gray solid thinnest lines) (the 











































However, since the surface-volume ratio of the equilateral cylinder is not so far from that of the rod-











           (22) 
Tm and Hm trends of the rod-shaped crystals are not so clearly detached from those of the equilateral 
one as in the case of parallelepiped-shaped crystals (Figure 4).  
 
Figure 7. Eq. (22) plot showing the dependence of the dimensionless ratio between crystal surface 
(As) and volume (Vs) on the shape ratio  = Ls/Rs at constant volume. The shaded cylinders 
qualitatively represent the shape of the crystals pertaining to the different  values. 
 
It is important to remind that the value of Xnc appears not to heavily affect the results shown in Figure 
4 and Figure 6, where Xnc = 1 was considered. 
It is now interesting to evaluate the effect of nano-crystals shape (sphere, cube ( =  = 1) and 
equilateral cylinder ( = 2)) on the Tm and Hm depression. Figure 8, concerning the melting process 
of spherical, cubic and (equilateral) cylindrical crystals, clarifies that, at equal crystal volume (VC), 
Tm and Hm of cubic nano-crystals are lower than those of cylindrical nano-crystals. In turn, 



















explanation of this behavior relies on both the dimensionless surface-volume ratio (cube → 3; 
equilateral cylinder → 2; sphere → 3) and the reduction of surface energy with surface curvature (1/r, 
see Eq. (13)). Indeed, not only cubic crystals are characterized by the highest value of the surface-
volume ratio, but they also show the highest surface energy as they are constituted by plane surfaces 
(curvature = 1/r → 0). 
 
Figure 8. Effect of geometry (sphere, cube ( =  = 1), equilateral cylinder ( = 2)) on the melting 
temperature Tm (left vertical axis, black lines) and enthalpy Hm (right vertical axis, gray lines) 
depression assuming the nano-crystals mass fraction Xnc = 1. The representation is inferiorly limited 
to the volume of approximately four Nimesulide unit cells ≈ 11 nm3. 
 
On the contrary, spherical crystals, although characterized by the same surface-volume ratio (3), 
suffer from the reduction of surface energy with curvature, this last one increasing as crystal radius 
decreases. Eq. (2) clarifies that, for vanishing values of lv and sl, Tm and Hm are independent of 
sphere radius. Cylindrical crystals are in between the spherical and cubic ones as they are 
characterized by the smallest surface-volume ratio, but the effect of curvature affects only the lateral 









































The findings of this paper are reflected in two crucial and practical aspects characterizing the nano-
crystals based delivery systems, i.e. the nano-crystals size distribution inside the polymeric carrier 
and nano-crystals water solubility.  
 
Figure 9. Effect of nano-crystals geometry (sphere, cube ( =  = 1) and parallelepiped ( = 0.01 and 
100;  = 1)) on their size distribution (f) referring to the Nimesulide-Polyvinylpyrrolidone (1:3) 
system described in ref. 21. Rsphere is the radius of the equivalent sphere sharing the same volume of 
the parallelepiped-shaped nano-crystals. Nimesulide unit cell half dimension corresponds to Rsphere = 
0.77 nm. 
 
For this purpose, it is useful to consider a system made by co-grinding, for one hour, NIM and 
crosslinked Polyvinylpyrrolidone (PVP) in a mass ratio 1:3.21 Relying on the presented model, on the 
DSC (Differential Scanning Calorimetry) characterization and the theoretical strategy performed by 
Coceani and co-workers,21 it is possible to evaluate the nano-crystals size distribution of the 
considered NIM-PVP system. To perform a more significant analysis of the geometry effects, it is 
convenient to express the nano-crystals size distribution (f(1/nm)) as a function of the radius, Rsphere, 
of the equivalent sphere sharing the same volume of the considered crystal. The inspection of Figure 
9 reveals that both distribution wideness and peak position increase when considering, in order, 























This result sounds reasonable as, in the case of spherical crystals, the size distribution lies very close 
to the physical limit of NIM nano-crystals, i.e. one-half of NIM unit cell (0.77 nm). On the contrary, 
when cubic nano-crystals are considered (whose shape is close to that of the real NIM crystals as 
predicted by the WinXMorph software68), the distribution moves towards larger radii. Finally, 
increasingly larger radii are considered by the rod and platelet distributions. These findings could 
contribute to explain why, presuming crystals to be spherical, the determination of crystals size by 
DSC is usually lower than that performed by means of the X-Rays approach.48,69 
Moving to the effect of geometry on nano-crystals water solubility, it is useful to recall the relation 





































































C    (23) 
where Xd is the drug molar solubility, d is the drug activity coefficient, hm and cp are, respectively, 
the drug molar melting enthalpy and the difference between the solid (drug) and the liquid (drug) 
molar specific heat at constant pressure, Md and Ms are, respectively, the drug and the solvent 
molecular weight, sol is the solvent density, R is the universal gas constant, while Cs is the 
mass/volume nano-crystal solubility. Eq. (23) derives from the classical theory of thermodynamic 
equilibrium between a solid phase (of component “1”) and a liquid one (of component “2”) assuming, 
as commonly done, that only the solid component (1) is able to spread between the solid and the 
liquid phase (i.e. the liquid phase is unable to dissolve in the solid crystalline network). Equating the 
fugacity of compound “1” in the solid and the liquid phase, Eq. (23) is obtained. This thermodynamic 
approach leads to the interesting conclusion that the solubility of “1” in the liquid phase also depends 
on Tm and the molar melting enthalpy (hm) of the solid phase. In particular, the lower Tm and hm, 
the higher the solubility of the solid phase in the liquid one, as witnessed by Figure 10 that depicts 
Eq. (23) outcomes concerning the solubility trend of spherical and cubic NIM nano-crystals (Xnc = 1) 
versus nano-crystals size up to NIM unit cell volume (2.77 nm3), a value corresponding to Rsphere = 
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0.87 nm. Figure 10, based, for the sake of simplicity, on the assumption that d is almost constant 
with concentration, allows evaluating the ratio Cs/Cs∞, where Cs∞ is the mass/volume solubility of the 
infinitely large NIM crystal. The choice of the cubic shape is dictated by the approximately cubic 
morphology of the real NIM nano-crystals as predicted by the WinXMorph software.68 It is clear that 
the cubic shape implies a more pronounced increase of solubility since cubic crystals are 
characterized by lower Tm and Hm with respect to spherical crystals of the same volume (see Figure 
8). Interestingly, the maximum theoretical solubility increase occurring for Rsphere → 0.87 nm 
(approximately eightfold), is compatible with the solubility increase of amorphous drugs (not 
chemically too dissimilar to NIM) lying in the range 10–100 (the amorphous drug is expected to be 
more soluble than the nano-crystalline drug).70,71 
 
Figure 10. Effect of nano-crystals geometry (sphere, cube ( =  = 1) on the ratio between the 
solubility of Nimesulide nano-crystals (Cs) and that of the infinitely large Nimesulide crystal (Cs∞) 
assuming the nano-crystals mass fraction Xnc = 1. Rsphere is the radius of a sphere sharing the same 
volume of the cubic nano-crystals. The simulation is arrested at the value corresponding to the 












On the basis of the previously provided evidence and with the aim of validating the trends predicted 
by the presented thermodynamic model, MD calculations were performed to derive Tm and Hm 
behavior of parallelepiped-shaped nano-crystals as a function of selected shape factors ( = 0.1, 1, 
10) for three small organic drugs. Figure 11 shows the comparison between the Tm and Hm reduction 
predicted by the thermodynamic model (Eqs. (9) and (10), continuous lines) with that obtained by the 
MD approach (open symbols). MD calculations confirm the decrease in Tm and Hm as a function of 
nano-crystal volume envisaged by the thermodynamic model. In addition, the influence of the shape 
ratio () at constant crystal volume is properly resolved. 
 
Figure 11. Comparison between the melting temperature Tm (left vertical axis) and enthalpy Hm 
(right vertical axis) decrease according to the thermodynamic model (Eqs. (9) and (10); solid black 
and gray lines, respectively) and to the molecular dynamics approach (symbols). The simulations 
were performed assuming Nimesulide nano-crystals in the form of parallelepipeds characterized by 
a square base ( = 1), three different values of the shape factor ( = 0.1, 1, 10) and the nano-crystals 










































A further verification of the model was performed by considering two other small organic drugs 
(nifedipine and griseofulvin, whose characteristics are reported in supporting information, Table S1 
and Table S2, respectively), always belonging to the Amidon class II (low water solubility and good 
permeability). Figures S1-S4 (see supporting information) show that a reasonable agreement between 
model predictions and MD simulations was achieved also for NIF and GRI. 
 
CONCLUSIONS 
The thermodynamic model developed in this paper allows evaluating the effect of size and shape on 
Tm and Hm of organic (drug) nano-crystals. In particular, the differences existing among spherical, 
cylindrical and parallelepiped-shaped nano-crystals, characterized by different shape ratios (from 
needles to platelets), are explained in terms of the ratio between the number of surface and bulk 
molecules. Indeed, the higher this ratio, the higher the Tm and Hm reductions are and, consequently, 
the higher the drug solubility is. As solubility increase is reflected in drug bioavailability 
enhancement, the considerable practical effect of nano-crystals geometry on nano-crystals based 
delivery systems clearly emerges. 
Model reliability, tested in the case of a well-known poorly water-soluble drug (Nimesulide, a 
nonsteroidal anti-inflammatory drug), is supported by the fact that the predicted solubility increase is 
physically sound in relation to the solubility of the amorphous drug, which is expected to be 
considerably higher. In addition, our model reliability was also proved by the results obtained from 
an MD approach, which confirms the Tm and Hm reduction predicted by the thermodynamic model 
and the effect of shape ratio variation. Accordingly, this model may be considered a reliable tool for 
the characterization/design of nano-crystals based delivery systems (determination of Xnc and nano-
crystals size distribution in polymer-drug systems) and for the evaluation of nano-crystals solubility 
increase, an aspect of paramount importance for the bioavailability enhancement of poorly water 
soluble drugs. In addition, as it relies on thermodynamics, the developed model potentially holds for 
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every drug and their polymorphic forms which may be considerably significant in the pharmaceutical 
field. Clearly, it requires the knowledge of a certain number of fundamental physical parameters such 
as surface tension, density, and Tm∞/Hm∞ of the specific drug/polymorphic species. 
Finally, the presented model constitutes the starting point for the development of a thermodynamic 
model able to consider the actual shape of drug nano-crystals (typically appearing in form of complex 
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APPENDIX 
Model numerical solution for parallelepiped (Eqs. (9)-(10)) 
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H  (A.2) 
Equating this Hm1 estimation to the Zhang’s one (Eq. (10)), it is possible to determine the values of 
as1 related to Tm1: 






























































   (A.3) 
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Once as1 is known, Hm1 may be evaluated according to Eq. (9) or Eq. (10). Repeating the same 
strategy for further reductions of Tm, the following general expression for asi is achieved: 
 




















































































a  (A4) 
Again, after finding asi, Hmi may be evaluated according to Eq. (9) or Eq. (10). In order to ensure 
the reliability of the numerical procedure, T was set equal to 0.1 K. 
 
Model numerical solution for cylinder (Eqs. (17)-(18)) 
The numerical solution strategy adopted is conceptually similar to that of parallelepipeds (T = 0.1 
K). However, in this case, the determination of Rsi is not straightforward since the surface energy of 
the lateral cylinder surface is Rsi dependent (see Eq. (13)). Accordingly, once the Hmi obtained from 
Eq. (17) is equated with Eq. (18), Rsi is determined according to the Newton’s method assuming a 
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Melting temperature/enthalpy and solubility depend on nano-crystals shape and size. In particular, 
for a given volume, cubic nano-crystals show lower melting point and higher solubility than 
“idealized” spherical nano-crystals. Indeed, cubic nano-crystals are characterized by a higher 
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